WebApr 13, 2024 · Plasma technology has recently been one of the potential candidates for the targeted treatment of cancers. In this work, Nightingale®, a non-thermal air plasma jet device, was used to activate lactated Ringer’s injection (LRI) for the in vitro inactivation of lung cancer cells—A549 and H1299. The optimal treatment condition and its effects on … WebMore recently, the hypoxic microenvironment has been proposed to provide the cancer stem cell a niche conducive to the maintenance of stem cell characteristics. 1,2 The TME has attracted attention over the years and has emerged as a critical target for cancer therapy, independent of cancer type. 3,4 Although considerable attention has been paid ...
A neutrophil mimicking metal-porphyrin-based nanodevice loaded …
WebMar 4, 2024 · Conventional cancer therapies suffer from severe off-target effects because most of them target critical facets of cells that are generally shared by all rapidly proliferating cells. The development of new therapeutic agents should aim to increase selectivity and therefore reduce side effects. WebNational Center for Biotechnology Information index fund cagr
Immunopotentiation effects of apigenin on NK cell proliferation …
WebMar 29, 2016 · In this study, we demonstrate that B19 directly inhibits TrxR1 enzyme activity to elevate oxidative stress and then induce ROS-mediated ER Stress and mitochondrial … WebIncorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells. Background: The sigma-2 receptor is an attractive target for tumor imaging and targeted therapy because it is overexpressed in multiple types of solid tumors, including prostate cancer, breast cancer, and lung cancer. WebJan 4, 2024 · Silica Nanoparticles (SNPs) have been found to exhibit higher cytotoxicity to various cancer cells than to normal cells, while the underlying mechanisms are not fully understood. Here, SNPs triggered much higher cytotoxicity and apoptosis rate in human hepatoma HepG2 cells than in their normal counterparts L-02 cells; we thus selected … index fund allocation